Influence of amlodipine on serum level of some cytokines in patients with congestive heart failure;Wpływ amlodypiny na stȩżenie wybranych cytokin u chorych na przewlekła̧ niewydolność kra̧żenia

Polskie Archiwum Medycyny Wewnetrznej

Volumn 109, Issue 2, 2003, Pages 149-155

  Salomon, Piotr ^a   Halawa, Bogumił ^a   Karolko, Bozena ^a  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Amlodipine; Congestive heart failure; Cytokines

Indexed keywords

AMLODIPINE; CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 6; NEUROPEPTIDE Y; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; MALE; RADIOIMMUNOASSAY;

EID: 0037234491     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bozkurt B., Kribbs S.B., Clubb F.J.: Patophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 1998, 97, 1382.
2. Neumann F.J., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schoming: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation, 1995, 92, 748.
3. Nakano M., Knowlton A.A., Dibbs Z., Mann D.L.: Tumor necrosis factor-α confers resistance to hypoxic injurry in the adult mammalian cardiac myocyte. Circulation, 1998, 97, 1392.
4. Maury C.P.J., Teppo A.M.: Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J. Intern. Med., 1989, 225, 333.
5. Torre-Amione G., Kapadia S., Lee J., Bies R.D., Lebovitz R., Mann D.L.: Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation, 1995, 92, 1487.
6. Kowalczyk D.: Monocyty i makrofagi. I. Ogólna charakterystyka. Przegla̧d Lek., 1991, 48, 705.
7. Vanderheyden M.E., Kersschot and W.J., Paulus: Proinflamatory cytokines and endothelium-dependent vasodilatation in the forearm. Eur. Heart J., 1998, 19, 747.
8. Hasper D.M., Hummel F.X., Klebert I., Reindlt and H.D. Volkt: Systemic inflammation in patients with heart failure. Eur. Heart J., 1998, 19, 761.
9. Fukuzawa M., Satoh J., Otha S. i wsp.: Modulation of tumor necrosis factor-alpha production with antihypertensive drugs. Immunopharmacology, 2000, 48(1), 65.
10. Matsumori M., Nunokawa Y., S. Sasayama: Nifedipine inhibits activation of transcription factor NF-kappaB. Life. Sci., 2000, 13, 2655.
11. Matsumori A., Ono K., Nishio R., Nose Y., Sasayama S.: Amlodipine inhibits the production of cytokines induced by ouabain. Cytokine 2000, 12, 294.
12. Mohler E.R., Sorensen L.C., Ghali J.K. i wsp.: Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. J. Am. Coll. Cardiol., 1997, 30, 35.
13. Eickelberg O., Roth M., Mussmann R., Rudiger J.J. i wsp.: Calcium chanel blocers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappa B in primary human vascular smooth muscle cells. Circulation, 1999, 2276.
14. Yang J.K., Fukuo S., Morimoto T. i wsp.: Pranidipine enhances the action of nitric oxide relased from endothelial cells. Hypertension, 2000, 35, 82.
15. Matsumori A.: The use of cytokine inhibitors. A new therapeutic insight into heart failure. Int. J. Cardiol., 1997, 1, S3.
16. Yu G., Liang X., Xie X., Su M., Zhao S.: Diverse effects of chronic treatment with losartan, fosinopril and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats. Int. J. Cardiol., 2001, 81, 123.
17. Munger M.A., Johnson B., Amber I.J., Callahan K.S.: Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathie. Am. J. Cardiol., 1996, 77, 723.